Skip to content. | Skip to navigation

Investigational New Drug (IND)



An Investigational New Drug application is provided to the FDA to obtain permission to test a new drug in humans in Phase I – III clinical studies. The IND is reviewed by the FDA to ensure that study participants will not be placed at unreasonable risk.


No

weekly

0.5

No